Summary
This Form 8-K filing from Amgen Inc. (AMGN) reports a revision to the estimated value of post-retirement benefits for its former CEO and Chairman, Mr. Kevin W. Sharer. As of July 26, 2013, the Compensation and Management Development Committee approved a modification to the support services provided to Mr. Sharer, which are set to continue for a five-year period from January 1, 2013, to December 31, 2017. The primary change involves an updated estimation of the cost for secretarial, travel, and technology support services. The company now anticipates these services will cost approximately $100,000 per year during the aforementioned five-year term. This disclosure provides transparency regarding executive compensation and post-employment arrangements, which is important for investors monitoring corporate governance and executive benefits.
Key Highlights
- 1Amgen Inc. reported on a revision to post-retirement benefits for former CEO and Chairman, Kevin W. Sharer.
- 2The Compensation and Management Development Committee of Amgen's Board of Directors approved the revision.
- 3The post-retirement benefits include secretarial, travel, and technology support services.
- 4These services are provided for a five-year period, from January 1, 2013, to December 31, 2017.
- 5The estimated annual cost for these services has been revised to approximately $100,000 per year.
- 6The filing is made under Item 5.02 of Form 8-K, relating to director and officer changes and compensation.